CoChat

Biofilm-Induced Antibiotic Resistance in Clinical Acinetobacter baumannii Isolates

Shenkutie, Abebe Mekuria, Yao, Mian Zhi, Siu, Gilman Kit-hang, Wong, Barry Kin Chung, Leung, Polly Hang-mei · 2020 · Antibiotics
Cited by 100

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

In order to understand the role of biofilm in the emergence of antibiotic resistance, a total of 104 clinical Acinetobacter baumannii strains were investigated for their biofilm-forming capacities and genes associated with biofilm formation. Selected biofilm-formers were tested for antibiotic susceptibilities when grown in biofilm phase. Reversibility of antibiotic susceptibility in planktonic cells regrown from biofilm were investigated. We found 59.6% of the strains were biofilm-formers, among which, 66.1% were non-multidrug resistant (MDR) strains. Presence of virulence genes bap, csuE, and abaI was significantly associated with biofilm-forming capacities. When strains were grown in biofilm state, the minimum biofilm eradication concentrations were 44, 407, and 364 times higher than the minimum bactericidal concentrations (MBC) for colistin, ciprofloxacin, and imipenem, respectively. Persisters were detected after treating the biofilm at 32–256 times the MBC of planktonic cells. Reversibility test for antibiotic susceptibility showed that biofilm formation induced reversible antibiotic tolerance in the non-MDR strains but a higher level of irreversible resistance in the extensively drug-resistant (XDR) strain. In summary, we showed that the non-MDR strains were strong biofilm-formers. Presence of persisters in biofilm contributed to the reduced antibiotic susceptibilities. Biofilm-grown Acinetobacter baumannii has induced antibiotic tolerance in non-MDR strains and increased resistance levels in XDR strains. To address the regulatory mechanisms of biofilm-specific resistance, thorough investigations at genome and transcription levels are warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/antibiotics9110817

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 31

  1. Fournier, 2006, The epidemiology and control of Acinetobacter baumannii in health care facilities, Clin. Infect. Dis., 42, 692, 10.1086/500202 · DOI · Paper page
  2. Piperaki, 2019, Carbapenem-resistant Acinetobacter baumannii: In pursuit of an effective treatment, Clin. Microbiol. Infect., 25, 951, 10.1016/j.cmi.2019.03.014 · DOI · Paper page
  3. Niu, 2020, Wza gene knockout decreases Acinetobacter baumannii virulence and affects wzy-dependent capsular polysaccharide synthesis, Virulence, 11, 1, 10.1080/21505594.2019.1700659 · DOI
  4. Leung, 2019, Emergence of carbapenem-resistant Acinetobacter baumannii ST195 harboring blaOxa-23 isolated from bacteremia in Hong Kong, Microb. Drug Resist., 25, 1199, 10.1089/mdr.2018.0433 · doi:10.1089/mdr.2018.0433
  5. Cheng, 2018, Control of multidrug-resistant Acinetobacter baumannii in Hong Kong: Role of environmental surveillance in communal areas after a hospital outbreak, Am. J. Infect. Control, 46, 60, 10.1016/j.ajic.2017.07.010 · DOI
  6. Gaddy, 2009, The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells, Infect. Immun., 77, 3150, 10.1128/IAI.00096-09 · DOI · Paper page
  7. Yang, C.H., Su, P.W., Moi, S.H., and Chuang, L.Y. (2019). Biofilm formation in Acinetobacter baumannii: Genotype-phenotype correlation. Molecules, 24. · DOI · Paper page
  8. Webb, 2006, Enhanced biofilm formation and increased resistance to antimicrobial agents and bacterial invasion are caused by synergistic interactions in multispecies biofilms, Appl. Environ. Microbiol., 72, 3916, 10.1128/AEM.03022-05 · DOI · Paper page
  9. Loehfelm, 2008, Identification and characterization of an Acinetobacter baumannii biofilm-associated protein, J. Bacteriol., 190, 1036, 10.1128/JB.01416-07 · DOI · Paper page
  10. Tomaras, 2003, Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: Involvement of a novel chaperone-usher pili assembly system, Microbiology, 149, 3473, 10.1099/mic.0.26541-0 · DOI · Paper page
  11. He, 2015, Biofilm formation caused by clinical Acinetobacter baumannii isolates is associated with overexpression of the adeFGH efflux pump, Antimicrob. Agents Chemother., 59, 4817, 10.1128/AAC.00877-15 · DOI · Paper page
  12. Peleg, 2008, Acinetobacter baumannii: Emergence of a successful pathogen, Clin. Microbiol. Rev., 21, 538, 10.1128/CMR.00058-07 · DOI · Paper page
  13. Visca, 2011, Acinetobacter infection–an emerging threat to human health, IUBMB Life, 63, 1048, 10.1002/iub.534 · DOI · Paper page
  14. Chen, 2014, Rapid identification of Acinetobacter baumannii, Acinetobacter nosocomialis and Acinetobacter pittii with a multiplex PCR assay, J. Med. Microbiol., 63, 1154, 10.1099/jmm.0.071712-0 · doi:10.1099/jmm.0.071712-0
  15. Bartual, 2005, Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii, J. Clin. Microbiol., 43, 4382, 10.1128/JCM.43.9.4382-4390.2005 · DOI · Paper page
  16. 2000, A Modified microtiter-plate test for quantification of staphylococcal biofilm formation, J. Microbiol. Methods, 40, 175, 10.1016/S0167-7012(00)00122-6 · DOI · Paper page
  17. Manchanda, 2010, Multidrug resistant Acinetobacter, J. Glob. Infect. Dis., 2, 291, 10.4103/0974-777X.68538 · DOI · Paper page
  18. Moskowitz, 2004, Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis, J. Clin. Microbiol., 42, 1915, 10.1128/JCM.42.5.1915-1922.2004 · DOI · Paper page
  19. Bogachev, M.I., Volkov, V.Y., Markelov, O.A., Trizna, E.Y., Baydamshina, D.R., Melnikov, V., Murtazina, R.R., Zelenikhin, P.V., Sharafutdinov, I.S., and Kayumov, A.R. (2018). Fast and simple tool for the quantification of biofilm-embedded cells sub-populations from fluorescent microscopic images. PLoS ONE, 13. · DOI
  20. Marques, 2015, Isolation of persister cells from biofilm and planktonic populations of Pseudomonas aeruginosa, Bio-Protocol, 5, e1590, 10.21769/BioProtoc.1590 · DOI
  21. Anghel, 2011, Pathogenic features and therapeutical implications of biofilm development ability in microbial strains isolated from rhinologic chronic infections, Farmacia, 59, 770
  22. Babapour, 2016, Biofilm formation in clinical isolates of nosocomial Acinetobacter baumannii and its relationship with multidrug resistance, Asian Pac. J. Trop. Biomed., 6, 528, 10.1016/j.apjtb.2016.04.006 · DOI
  23. Qi, 2016, Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Acinetobacter baumannii, Front. Microbiol., 7, 483, 10.3389/fmicb.2016.00483 · DOI · Paper page
  24. Marti, 2008, Biofilm formation in Acinetobacter baumannii: Associated features and clinical implications, Clin. Microbiol. Infect., 14, 276, 10.1111/j.1469-0691.2007.01916.x · DOI · Paper page
  25. Wang, 2018, Biofilm formation is not associated with worse outcome in Acinetobacter baumannii bacteraemic pneumonia, Sci. Rep., 8, 7289, 10.1038/s41598-018-25661-9 · DOI
  26. Perez, 2015, Acinetobacter baumannii displays inverse relationship between meropenem resistance and biofilm production, J. Chemother., 27, 13, 10.1179/1973947813Y.0000000159 · doi:10.1179/1973947813y.0000000159
  27. Brossard, 2012, The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells, Infect. Immun., 80, 228, 10.1128/IAI.05913-11 · DOI · Paper page
  28. Bagge, 2004, Dynamics and spatial distribution of β-lactamase expression in Pseudomonas aeruginosa biofilms, Antimicrob. Agents. Chemother., 48, 1168, 10.1128/AAC.48.4.1168-1174.2004 · DOI · Paper page
  29. Pamp, 2008, Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes, Mol. Microbiol., 68, 223, 10.1111/j.1365-2958.2008.06152.x · DOI · Paper page
  30. Bernier, S.P., Lebeaux, D., DeFrancesco, A.S., Valomon, A., Soubigou, G., Coppée, J.Y., Ghigo, J.M., and Beloin, C. (2013). Starvation, together with the sos response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin. PLoS Genet., 9. · DOI · Paper page
  31. Page, 2016, Toxin-antitoxin systems in bacterial growth arrest and persistence, Nat. Chem. Biol., 12, 208, 10.1038/nchembio.2044 · DOI · Paper page

Metadata

Authors
Shenkutie, A. M., Yao, M. Z., Siu, G. K.-H., Wong, B. K. C., & Leung, P. H.-M.
Venue
Antibiotics
Publisher
MDPI AG
Published
2020-11-17
Volume
9
Issue
11
Pages
817
ISSN
2079-6382
Cited by
100
References
2
Language
en
Funders
The Hong Kong PhD Fellowship Scheme (PH16-01625)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biofilm-Induced Antibiotic Resistance in Clinical Acinetobacter baumannii Isolates. https://app.cochat.ai/papers/10.3390/antibiotics9110817
The paper
Shenkutie, A. M., Yao, M. Z., Siu, G. K.-H., Wong, B. K. C., & Leung, P. H.-M. (2020). Biofilm-Induced Antibiotic Resistance in Clinical Acinetobacter baumannii Isolates. Antibiotics. https://doi.org/10.3390/antibiotics9110817

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.